In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee:
Time and Date: 8 a.m.-5:30 p.m., October 21, 2009; 8 a.m.-4:30 p.m., October 22, 2009.
Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road, NE., Building 19, Kent “Oz” Nelson Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines.
Matters to be Discussed: The agenda will include discussions on: Human Start Printed Page 51613Papillomavirus (HPV) Vaccines; 2010 Childhood & Adolescent Immunization Schedule; 2010 Adult Immunization Schedule; General Recommendations; Respiratory Syncytial Virus; Meningococcal Vaccines; Yellow Fever Vaccine; Rotavirus Vaccines; 13-Valent Pneumococcal Conjugate Vaccine; and Influenza Vaccines. Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Antonette Hill, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., (E-05), Atlanta, Georgia 30333, telephone 404/639-8836, fax 404/639-8905.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR.Start Signature
Dated: September 30, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. E9-24157 Filed 10-6-09; 8:45 am]
BILLING CODE 4160-18-P